Osteonecrosis of the jaw in a Crohn’s disease patient following a course of Bisphosphonate and Adalimumab therapy: a case report

BACKGROUND: Bisphosphonates have a widespread indication for osteoporosis and are also applied in cancer patients with skeletal-related conditions. Bisphosphonate-associated osteonecrosis of the jaw (BRONJ) is a feared side effect which is hard to treat and often affects patient´s quality of life in...

Descripción completa

Detalles Bibliográficos
Autores principales: Preidl, Raimund HM, Ebker, Tobias, Raithel, Martin, Wehrhan, Falk, Neukam, Friedrich W, Stockmann, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890650/
https://www.ncbi.nlm.nih.gov/pubmed/24400722
http://dx.doi.org/10.1186/1471-230X-14-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890650/
https://www.ncbi.nlm.nih.gov/pubmed/24400722
http://dx.doi.org/10.1186/1471-230X-14-6

Ejemplares similares